use of lattoferrina for the topical therapy of acute or recurrent infections caused by streptococcus pyogenes or other

摘要

some pathogenic bacteria are able to penetrate within human cells remain viable in the fagosoma or replicate in the cytoplasm leaking from the vacuole.lisando the cell and spreading the infection.in this patent is demonstrated for the first time, regardless of its antibacterial activity.a antiinvasiva activity towards gram + organisms intracellular pathogens possessed by the lattoferrina, glycoprotein present in secretions and leukocytes in granules of neutrophils.to a lesser extent, also polipeptidici fragments of protein and other transferrine, altered chemically, for example, the ovotransferrina glycosylated.show the same activity antiinvasiva.it was we noted that the lattoferrina has a protection activities of human epithelial cells in culture from invasion of streptococcus pyogenes and staphylococcus aureus.pathogenic microorganisms, gram +, which proved to be the ability to invade human cells.the lattoferrina, preventing these microorganisms to "hide" within the cells.it makes them aggredibili by drug therapy and cell factors and mood are the body's defences.the activities of the lattoferrina antiinvasiva.it can be generalized and usable for the topical therapy of many acute or recurrent bacterial infections of skin and mucous membranes by which oropharyngeal, nasal, intestinalbronchial, vaginal and other. finally, it is known as the lattoferrina is absolutely harmless for topical use and can be produced industrially in large quantities.